FDA plans to develop guidance to help COVID-19 vaccine, drug and testing manufacturers adapt to emerging variants of the SARS-CoV-2 virus.
Author: Karen Weintraub, USA TODAY
From fiery crash to medical miracle: New Jersey man is world’s first to receive successful face and double-hand transplant
After a car accident destroyed his face and arms, Joseph DiMeo determined to recover his independence. Now, after complex transplant surgery, he has.
Only 38% of nursing home workers accepted COVID-19 vaccines, new data shows
The first national-level figures show just 38% of nursing home staff members accepted the vaccine in early weeks, the CDC reported Monday.
Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided immunity against new variants
The Novavax vaccine candidate also appears to be effective against the UK and South African coronavirus variants.
The first 22M Americans have been vaccinated for COVID-19, and initial safety data shows everything is going well, CDC says
Side effects remain a common result of both the Pfizer-BioNTech and Moderna vaccines, with 70% of people who self-reported saying they suffered pain.
Biden administration renewed support for World Health Organization is ‘good news for America and the world,’ scientists say
Health experts say reversing Trump administration withdrawal from the international body is good news for the WHO, America and the world.
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.
Moderna struggles to find 3,000 adolescent volunteers needed for COVID-19 vaccine trial
More than 2 million minors were diagnosed with COVID-19 in 2020, and many more probably contracted the disease but were never diagnosed.
Millions of Americans with intellectual disabilities, at ‘particularly high risk’ for COVID-19, are still waiting for vaccinations
The vaccine priority level for people who live in group homes varies by state – even though they are more likely to be exposed to and die from COVID.
New coronavirus variants aren’t cause for alarm yet, but mutations could make COVID-19 harder to fight, experts say
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.